Value of Lung Ultrasound Sonography B-Lines Quantification as a Marker of Heart Failure in COPD Exacerbation.
Humans
Pulmonary Disease, Chronic Obstructive
/ diagnostic imaging
Male
Female
Heart Failure
/ diagnostic imaging
Aged
Prospective Studies
Cross-Sectional Studies
Lung
/ diagnostic imaging
Predictive Value of Tests
Middle Aged
Ultrasonography
Disease Progression
Area Under Curve
ROC Curve
Aged, 80 and over
Natriuretic Peptide, Brain
/ blood
Reproducibility of Results
Prognosis
Peptide Fragments
COPD
chronic obstructive pulmonary disease
dyspnea
heart failure
lung ultrasound sonography
Journal
International journal of chronic obstructive pulmonary disease
ISSN: 1178-2005
Titre abrégé: Int J Chron Obstruct Pulmon Dis
Pays: New Zealand
ID NLM: 101273481
Informations de publication
Date de publication:
2024
2024
Historique:
received:
13
12
2023
accepted:
07
07
2024
medline:
7
8
2024
pubmed:
7
8
2024
entrez:
7
8
2024
Statut:
epublish
Résumé
Identifying heart failure (HF) in acute exacerbation of chronic obstructive pulmonary disease (AECOPD) can be challenging. Lung ultrasound sonography (LUS) B-lines quantification has recently gained a large place in the diagnosis of HF, but its diagnostic performance in AECOPD remains poorly studied. This study aimed to assess the contribution of LUS B-lines score (LUS score) in the diagnosis of HF in AECOPD patients. This is a prospective cross-sectional multicenter cohort study including patients admitted to the emergency department for AECOPD. All included patients underwent LUS. A lung ultrasound score (LUS score) based on B-lines calculation was assessed. A cardiac origin of dyspnea was retained for a LUS score greater than 15. HF diagnosis was based on clinical examination, pro-brain natriuretic peptide levels, and echocardiographic findings. The LUS score diagnostic performance was assessed by receiver operating characteristic (ROC) curve, sensitivity, specificity, and likelihood ratio at the best cutoffs. We included 380 patients, mean age was 68±11.6 years, sex ratio (M/F) 1.96. Patients were divided into two groups: the HF group [n=157 (41.4%)] and the non-HF group [n=223 (58.6%)]. Mean LUS score was higher in the HF group (26.8±8.4 vs 15.3±7.1; Our results suggest that LUS score could be helpful and should be considered in the diagnostic approach of HF in AECOPD patients, at least as a ruling in test.
Identifiants
pubmed: 39108664
doi: 10.2147/COPD.S447819
pii: 447819
pmc: PMC11300558
doi:
Substances chimiques
Natriuretic Peptide, Brain
114471-18-0
pro-brain natriuretic peptide (1-76)
0
Peptide Fragments
0
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1767-1774Informations de copyright
© 2024 Lajili et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.